Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: What is new?
Arthritis Research & Therapy, 05/28/09
Vercoulen Y et al. – A Review on the role of heat shock proteins (HSPs), especially HSP60, in modulating immune responses in both experimental and human arthritis, with a focus on juvenile idiopathic arthritis (JIA). The tolerogenic immune responses induced by HSPs, which could have a beneficial effect in JIA is also discussed. The immune modulatory capacity of HSPs, and the underlying mechanisms of HSP60-mediated immune regulation in JIA, and how this can be translated into therapy is the main focus of this article.
- HSPs in general can induce a tolerogenic immune response, in vitro, in vivo, and also in clinical trials in RA and type 1 diabetes
- This tolerogenic response is marked by the induction of IL-10, an immune suppressive cytokine
- Previous attempts at treatment with recombinant IL-10 in clinical trials have not led to improvements in RA pts
- HSPs probably not only increase IL-10 production by T cells, but also promote interactions of these cells with other immune cells, eventually leading to a tolerogenic response
- Towards therapy:
- To create a therapeutic window for HSPs, it may be important to first dampen chronic inflammation in the joints by using anti-TNFα therapy
- Second, the combination of HSPs and modulators of innate immunity, such as pathogenic patterns, should be investigated more thoroughly
- The combination of these two immune modulators may induce a stronger and longer lasting effect on the immune system by HSPs
Related Articles
Monitoring methotrexate toxicity in juvenile idiopathic arthritis
Journal of Rheumatology, 11/19/09
Relevance Score: 90%
B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients
Arthritis & Rheumatism, 11/04/09
Relevance Score: 89%
Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis
Arthritis Research & Therapy, 10/06/09
Relevance Score: 89%
Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis
Arthritis & Rheumatism, 11/09/09
Relevance Score: 87%
Systemic JIA: new developments in the understanding of the pathophysiology and therapy
Best Practice & Research: Clinical Rheumatology, 10/28/09
Relevance Score: 85%
Today in Pediatric Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
A new graph and scoring system simplified analysis of changing states: disease remissions in a rheumatoid arthritis clinical trial
Journal of Clinical Epidemiology, 12/11/09
Association of juvenile idiopathic arhrtitis and functional constipation
International Journal of Clinical Rheumatology, 12/04/09
Systemic vasculitis in childhood
Current Rheumatology Reports, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


